Currently out of the existing stock ratings of Leah Cann, 2708 are a BUY (98.76%), 34 are a HOLD (1.24%).

Leah Cann

Work Performance Price Targets & Ratings Chart

Analyst Leah Cann works at BROOKLINE with a stock forecast success ratio of 41.67% fulfilled within 191.5 days on average. Previously, Leah Cann worked at OPPENHEIMER.

Leah Cann’s has documented 130 price targets and ratings displayed on 14 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on MRNA, Moderna at 22-Jun-2022.

Wall Street Analyst Leah Cann

Analyst best performing recommendations are on SYRS (SYROS PHARMACEUTICALS).
The best stock recommendation documented was for MRNA (MODERNA) at 11/25/2020. The price target of $164 was fulfilled within 13 days with a profit of $54.82 (50.21%) receiving and performance score of 38.62.

Average potential price target upside

AMGN Amgen CELG Celgene CTIC CTi Biopharma Corp MEIP MEI Pharma MRNA Moderna SQZ Sqz Biotechnologies Co CCCC C4 Therapeutics  CRBU Caribou Biosciences KURA Kura Oncology SYRS Syros Pharmaceuticals MRTX Mirati Ther NTLA Intellia Therapeutics VSTM Verastem XFOR X4 Pharmaceuticals

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

350

$63.7 (22.25%)

258

1 months 20 days ago

1/2 (50%)

$57.44 (19.63%)

325

Buy

329

$42.7 (14.91%)

300

1 months 21 days ago

6/8 (75%)

$35.42 (12.06%)

68

Buy

350

$63.7 (22.25%)

310

1 months 27 days ago

29/30 (96.67%)

$27.96 (8.68%)

508

Hold

314

$27.7 (9.68%)

272

1 months 28 days ago

8/8 (100%)

$2.98 (0.96%)

96

Buy

345

$58.7 (20.50%)

310

2 months 25 days ago

22/23 (95.65%)

$46.64 (15.63%)

610

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Leah Cann?

On 2016

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?